← Patent-cliff monitor small molecule PAXLOVID (COPACKAGED) NIRMATRELVIR; RITONAVIR
Loss of exclusivity October 2041 latest FDA-listed patent expiry
Company Pfizer → See this company's full patent-cliff portfolio Drug detail Brand name PAXLOVID (COPACKAGED) Active ingredient NIRMATRELVIR; RITONAVIR Strength 150MG;100MG Dosage form TABLET Route ORAL Modality Small molecule FDA approval May 2023 Marketing status RX
Listed patents Patent Expires Type 11541034 October 2041 use U-3629 11351149 August 2041 substance, product
Regulatory exclusivity Code Expires NCE May 2028 D-195 January 2028
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.